Cov kev tshawb fawb niaj hnub no hauv cov metabolism tau qhia peb qee txoj kev nthuav dav uas peptide tuaj yeem cuam tshuam nrog ntau lub tshuab receptor tib lub sijhawm. Los ntawm kev siv plaub txoj kev sib txawv receptor kom muaj kev sib koom ua ke ntawm lub cev, Bioglutide NA-931 peptide sawv cev rau txoj hauv kev nyuaj ntawm kev tswj cov metabolism. Cov kws tshaj lij kws kho mob thiab cov tuam txhab biotechnology txaus siab heev rau qhov kev sib xyaw peptide siab heev vim lawv xav kawm ntxiv txog yuav ua li cas ntau tus neeg txais kev noj qab haus huv agonism tuaj yeem siv rau hauv daim ntawv thov kev noj qab haus huv metabolic.Tom ntej: Bioglutide NA-931 peptidelub peev xwm los qhib rau plaub lub tshuab receptor no muab cov ntaub ntawv tseem ceeb rau peb txog seb nws ua haujlwm li cas. Thaum GLP-1, GIP, glucagon, thiab IGF-1 receptors tau qhib rau tib lub sijhawm, lawv ua rau cov lus teb metabolic uas txawv heev los ntawm cov txheej txheem uas tsuas yog qhib ib lub receptor. Txhawm rau txhim kho kev tshawb fawb txog metabolic, pawg tshawb fawb thiab cov tuam txhab tshuaj thoob plaws ntiaj teb tab tom saib rau hauv cov kev sib raug zoo ntawm ntau yam -1. Bioglutide NA-931 muaj cov qauv tshwj xeeb uas cia nws khi rau plaub hom receptors. Qhov no teeb tawm cais tab sis ntxiv kev taw qhia txoj hauv kev. Cov kws tshawb fawb tuaj yeem siv ntau hom phiaj no los kawm ntau yam txog cov txheej txheem biochemical nyuaj ua haujlwm ua ke. Raws li kev lag luam kws tshuaj pheej nrhiav cov tshuaj peptide tshiab, nws tseem ceeb dua thiab ntau dua rau cov pab pawg txhim kho thiab kawm cov tsev kawm kom nkag siab tias cov txheej txheem receptor tshwj xeeb ua haujlwm li cas.
Tom ntej: Bioglutide NA-931
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) Cov ntsiav tshuaj
(3) Capsules
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Internal Code: KP-2-6/002
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.
Peb muab bioglutide NA-931, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia thiab cov khoom lag luam.
Khoom siv:https://www.kpeptide.com/bodybuilding-peptide/bioglutide-na-931.html
Dab tsi yog Plaub Receptors Targeted los ntawm Bioglutide NA-931 peptide
Glucagon Receptor: Sib npaug Hepatic Glucose Output
bioglutide NA-931 peptide kuj tseem tuaj yeem cuam tshuam rau glucagon receptor pathway, uas ua lub luag haujlwm tseem ceeb hauv kev tswj cov ntshav qabzib los ntawm kev tsim cov piam thaj hauv siab. Glucagon receptors feem ntau nyob hauv daim siab, qhov chaw uas lawv ua kom cov piam thaj tso rau hauv cov hlab ntsha. Kev hloov pauv ntawm txoj kev no, tshwj xeeb tshaj yog los ntawm kev txwv tsis pub muaj glucagon signaling nyob rau hauv cov xwm txheej hyperglycemic, pab txo qis cov piam thaj ntau dhau. Qhov kev sib raug zoo ntawm insulin thiab glucagon txoj hauv kev txhawb nqa kev tswj glycemic ruaj khov thiab cuam tshuam txog kev tswj hwm kev noj qab haus huv ntau dua ntawm cov txheej txheem metabolic.
GIP Receptor: Ntxiv Incretin Signaling
Lwm qhov tseem ceeb receptor tsom los ntawm bioglutide NA-931 peptide yog cov piam thaj -dependent insulinotropic polypeptide (GIP) receptor. Zoo ib yam li GLP-1 receptors, GIP receptors tau nthuav tawm ntawm pancreatic beta hlwb thiab pab txhawb rau cov piam thaj-dependent insulin secretion. Txawm li cas los xij, GIP signaling kuj txuas mus rau cov ntaub so ntswg adipose thiab pob txha, qhia txog lub luag haujlwm ntawm metabolic. Kev ua kom cov receptor no tuaj yeem txhim kho cov lus teb rau insulin thaum tseem cuam tshuam rau lipid metabolism thiab lub zog cia. Kev sib xyaw ua ke ntawm GLP-1 thiab GIP receptors tsim cov nyhuv incretin synergistic, txhim kho tag nrho cov txheej txheem metabolic tshaj li qhov kev xav tau ib leeg tuaj yeem ua tiav.
IGF-1 Txoj Kev: Kev Loj Hlob thiab Kev Tswj Xyuas Metabolic
Lwm qhov tseem ceeb receptor system uas Bioglutide NA-931 peptide cuam tshuam yog txoj kev loj hlob zoo li insulin-1 (IGF-1). IGF-1 receptors pab tswj cov metabolism, kev loj hlob ntawm tes, thiab cov protein ntau hauv ntau hom ntaub so ntswg. Lub stimulation ntawm cov receptor no yog ib feem ntawm peptide ntau yam ntawm metabolic kev ua uas mus tshaj li tswj cov piam thaj. Bioglutide NA-931 peptide 's activation ntawm IGF-1 txoj kev ntxiv ib theem tshiab ntawm anabolic signaling. Cov kws tshawb fawb uas tab tom kawm cov peptide no tuaj yeem pom tias cov cim kev loj hlob thiab kev tswj cov metabolic cuam tshuam li cas. Qhov no pab lawv nkag siab tias txoj kev sib koom ua ke ntawm lub cev muaj zog ua haujlwm li cas.
GLP-1 Receptor: Thawj Txoj Kev Incretin
Ib lub hom phiaj tseem ceeb rau Bioglutide NA-931 peptide yog glucagon-zoo li peptide -1 (GLP-1) receptor. Cov receptor no yog ib feem ntawm chav kawm B G-protein-coupled receptor tsev neeg thiab tseem ceeb heev rau kev khaws cov piam thaj kom ruaj khov. Thaum Bioglutide NA-931 txuas mus rau GLP-1 receptors, uas feem ntau pom ntawm pancreatic beta hlwb, nws tso tawm cov xwm txheej hauv cov hlwb uas ua rau cov piam thaj-dependant insulin ntau lawm. Bioglutide NA-931 peptide stimulation ntawm GLP-1 receptors kuj cuam tshuam rau thaj tsam satiety hauv lub hlwb thiab qaum qaum, tshwj xeeb tshaj yog nyob rau hauv hypothalamus. Txoj kev GLP-1 yog qhov muaj txiaj ntsig zoo rau kev tshawb fawb metabolic vim tias nws cuam tshuam rau ob qho tib si pancreatic thiab neural hlwb. Vim tias cov receptor muaj nyob hauv ntau lub cev.
Yuav ua li cas GLP-1 thiab GIP Pathways tau qhib los ntawm Bioglutide NA-931 peptide
Molecular Binding Mechanisms ntawm GLP-1 Receptors
Bioglutide NA-931 peptide muaj qee yam molecular yam ntxwv uas Bioglutide NA-931 peptide ua kom yooj yim rau nws khi rau GLP-1 receptors nrog siab affinity.Lub peptide's amino acid sequence muaj qhov tseem ceeb uas txuas nrog thaj tsam extracellular ntawm cov receptor thiab ua rau cov kev hloov pauv hloov pauv uas xav tau. Cov kev sib cuam tshuam ntawm cov molecules teeb tawm G-protein coupling, uas muaj Gs proteins uas tig rau adenylyl cyclase. Thaum GLP-1 receptor tshwm sim, cov qib cyclic AMP (cAMP) nce hauv cov phiaj hlwb. Qhov no yog lub ntsiab thib ob tub txib system uas tau pib.
Bioglutide NA-931 peptide activates GLP-1 thiab GIP receptors tib lub sijhawm. Qhov no muaj cov teebmeem metabolic uas ntau dua li cov txiaj ntsig ntawm txhua txoj hauv kev ua haujlwm ib leeg.Qhov kev sib koom ua ke no qhia tau tias muaj cov tshuaj insulin ntau dua, kev tshem tawm cov piam thaj zoo dua, thiab txuas cov kev cuam tshuam metabolic hauv ntau hom ntaub so ntswg. Pharmaceutical research pawg uas kawm txog incretin biology siv cov peptide no los saib cov teebmeem no thaum lawv sib xyaw. Muaj pov thawj tias dual incretin receptor activation hloov txoj kev beta hlwb ua haujlwm nyob rau hauv ib txoj kev uas txawv ntawm ib txoj kev stimulation. Thaum cov cim no tuaj ua ke, lawv zoo li tiv thaiv cov kab mob pancreatic thaum khaws cov tshuaj insulin kom muaj zog.
Lub luag haujlwm ntawm Glucagon Receptor Activation hauv Bioglutide NA-931 peptide Function
Hepatic Metabolic Modulation Los ntawm Glucagon Signaling
Bioglutide NA-931 peptide stimulation ntawm glucagon receptors feem ntau cuam tshuam cov metabolism hauv lub siab, bioglutide NA-931 peptide qhov twg cov receptors no pom muaj ntau tus lej. Cov peptide cuam tshuam nrog daim siab glucagon receptors, uas ua kom cov txheej txheem ua kom qabzib thiab hlawv rog. Thaum koj saib cov qauv kev ua haujlwm no nrog rau lub tsev thaiv cov teebmeem ntawm GLP-1 thiab GIP receptor kev koom tes, koj tuaj yeem pom qhov sib npaug ntawm cov metabolism. Glucagon receptor activation muaj kev cuam tshuam rau daim siab uas suav nrog cov roj fatty acid oxidation zoo dua, uas cov kws tshaj lij pom tias lub siab siv zog ntau dua.
Qhov tseeb tias Bioglutide NA-931 tuaj yeem tig rau txoj hauv kev no thiab incretin receptors tib lub sijhawm qhia tau hais tias muaj cov txheej txheem sib npaug sib npaug.Cov ntawv cog lus kev tsim kho thiab cov koom haum tsim khoom (CDMOs) uas ua haujlwm nrog cov peptide no paub tias nws tseem ceeb npaum li cas los ua kom cov kev ua haujlwm receptor tsis tu ncua thaum lub sijhawm tsim khoom. Bioglutide NA-931 stimulation ntawm glucagon receptors yog txawv los ntawm tus qauv glucagon agonism nyob rau hauv cov nqe lus ntawm nws muaj zog npaum li cas thiab nws kav ntev npaum li cas. Cov peptide zoo li txhawb nqa glucagon receptors nyob rau hauv ib qho me me thiab ntev-ntev txoj kev, es tsis yog txoj kev muaj zog thiab ceev uas haiv neeg glucagon ua. Cov molecule yog qhov nthuav heev rau kev tswj cov kev tshawb fawb metabolic vim tias nws qhov kev ua kom muaj peev xwm hloov tau.
Sib npaug Anabolic thiab Catabolic Signaling
Lub triggering ntawm glucagon receptors nyob rau hauv Bioglutide NA-931 peptide tsim ib tug tshwj xeeb metabolic tshuav nyiaj li cas ntawm cov txheej txheem uas tsim thiab ua puas hlwb. GLP-1 thiab GIP txoj hauv kev pab lub cev ua cov tshuaj insulin thiab khaws cov khoom noj, thaum cov cim glucagon pab lub cev siv thiab txav mus los. Qhov kev pom qhov tsis sib haum xeeb no yog qhov ua piv txwv nyuaj ntawm kev sib koom ua ke ntawm metabolic uas cov kws tshaj lij pom tau zoo heev. Cov kev siv tshuaj niaj hnub uas tsom rau ib leeg receptors yog qhov sib tw los ntawm qhov tseeb tias ib qho peptide molecule tuaj yeem sib npaug ntawm kev ua kom muaj ob txoj hauv kev. Bioglutide NA-931 peptide tab tom saib los ntawm cov tuam txhab tshuaj vim lawv paub.
Yuav ua li cas IGF-1 Txoj Kev Txhim Kho Metabolic Balance hauv Bioglutide NA-931 peptide
IGF-1 Receptor Kev Koom Tes thiab Anabolic Signaling
Bioglutide NA-931 peptide qhib txoj hauv kev IGF-1, uas muab nws lub cev Bioglutide NA-931 peptide ua lwm qhov. IGF-1 receptors, uas yog lub cev zoo ib yam li insulin receptors, pab ntau hom ntaub so ntswg loj hlob los ntawm kev txhawb nqa anabolism thiab kev loj hlob. Thaum Bioglutide NA-931 khi rau cov receptors no, nws pib qhia txoj hauv kev nrog PI3K thiab MAPK. Cov kev taw qhia no pab ua cov proteins, loj hlob hlwb, thiab ua kom lawv ciaj sia nyob rau hauv txoj kev uas ua hauj lwm nrog rau lwm yam peb receptor systems ' metabolic teebmeem.
Cov pab pawg tshawb fawb uas tab tom saib mus rau hauv Bioglutide NA-931 tau pom tias ua kom txoj hauv kev IGF-1 pab ua kom cov leeg nqaij thiab plab zom mov noj qab haus huv. Qhov kev taw qhia anabolic no ua rau peptide txawv ntawm cov molecules uas tsuas yog ua los ntawm incretins. Bioglutide NA-931 zoo li hloov qhov ntev thiab lub zog ntawm IGF-1 txoj kev stimulation piv rau natural IGF-1 signaling, tsim kom muaj kev tswj xyuas anabolic stimulus. Cov kws tshawb fawb kws tshuaj zoo li qhov ntsuas qhov ua kom pom tseeb vim tias ntau dhau IGF-1 cov cim qhia yuav ua rau muaj kev phom sij, tab sis kev ua kom nruab nrab yuav muaj kev nyab xeeb dua. Lub peptide's balanced mus kom ze rau kev khi rau IGF-1 receptor qhia tau hais tias nws tau tsim zoo npaum li cas ntawm qib molecular.
Cov ntaub so ntswg-Cov lus teb tshwj xeeb rau IGF-1 Txoj Kev Ua Haujlwm
Txoj hauv kev IGF-1, ua kom ib feem ntawm Bioglutide NA-931 peptide, muaj cov teebmeem sib txawv ntawm cov kabmob sib txawv.
Cov ntaub so ntswg adipose muaj kev ua haujlwm zoo hauv metabolic, thaum cov nqaij pob txha siv cov piam thaj ntau dua thiab ua rau cov protein ntau.
Cov lus teb uas tshwj xeeb rau cov ntaub so ntswg ntxiv rau peptide tag nrho cov teebmeem metabolic thiab muab cov kws tshawb fawb ntau qhov chaw los nrhiav cov lus qhia rau lawv cov kev tshawb fawb.
Tsis tas li ntawd, IGF-1 ib feem zoo li muaj kev cuam tshuam rau cov pob txha metabolism, txawm hais tias qhov txiaj ntsig no tseem tab tom kawm los ntawm pawg kawm.
Bioglutide NA-931 yog cov cuab yeej siv tau zoo rau cov kws tshawb fawb kawm seb lub cev lub cev ua haujlwm li cas vim tias nws tuaj yeem cuam tshuam rau ob qho tib si metabolic thiab cov ntaub so ntswg. Txhawm rau khaws cov teebmeem no rau ntau cov ntaub so ntswg, cov koom haum tshawb fawb cog lus uas ua haujlwm nrog cov peptide no yuav tsum xyuas kom meej tias qhov zoo ib yam.
Vim li cas Multi-Receptor Activation Ua Bioglutide NA-931 peptide Cim
Qhov zoo ntawm Simultaneous Pathway Engagement
Bioglutide NA-931 peptide yog qhov tshwj xeeb vim nws tuaj yeem cuam tshuam nrog plaub qhov sib txawv receptor systems tib lub sijhawm. Thaum muaj ntau yam receptors tau qhib, cov kev xav ntawm lub cev tshwm sim uas txawv heev los ntawm cov tshuaj uas tsuas yog tsom rau ib qho receptor. Cov tuam txhab tshuaj thiab cov tsev kawm tshawb fawb tau paub tias kev ua haujlwm ua ke tib lub sijhawm yuav pab tau rau kev kawm paub ntxiv txog Bioglutide NA-931 peptide thiab cov txheej txheem lom neeg ua haujlwm li cas. Cov txheej txheem ib txwm siv hauv pharmacology feem ntau tsom rau kev xaiv ua kom cov receptors kom muaj kev phiv tsawg kawg nkaus.
Bioglutide NA-931 peptide nug lub tswv yim no los ntawm lub hom phiaj ua kom muaj ntau txoj hauv kev sib txuas uas ua haujlwm ua ke kom muaj kev sib koom ua ke ntawm metabolic. Txoj kev no qhia tau hais tias peb txoj kev paub txog metabolic physiology li cas rau tag nrho cov kab ke, tsis yog ib pawg ntawm cov txheej txheem cais, tab tom loj hlob.Qhov peptide no muaj txiaj ntsig zoo rau cov pab pawg tshawb fawb biotechnology uas kawm txog cov txheej txheem biology. Thaum Bioglutide NA-931 activates plaub lub receptor systems, lawv ua hauj lwm ua ke los ua cov yam ntxwv tshiab uas yuav tsis tshwm sim yog tias tsuas yog ib txoj hauv kev tau txhawb nqa. Cov kev sib cuam tshuam no tshwm sim raws li kev hloov pauv ntawm cov metabolism, kev faib tawm zoo dua ntawm cov as-ham, thiab kev sib koom ua ke ntawm cov ntaub so ntswg.
Kev sib tw thiab kev txiav txim siab hauv Multi-Receptor Compounds
Multi-receptor activation muaj qee qhov txiaj ntsig zoo, tab sis nws kuj ua rau tej yam nyuaj rau cov kws tshawb fawb uas ua haujlwm nrog Bioglutide NA-931 peptide . Nws yog ib qho nyuaj rau khaws ib lub qhov muag ntawm plaub txoj kev receptor tib lub sijhawm, yog li koj xav tau cov txheej txheem analytical siab thiab cov qauv tsim kom zoo. Cov koom haum tsim kev cog lus (CDMOs) uas pab nrog kev tshawb fawb siv cov peptide no yuav tsum muab cov kws tshawb fawb tshawb xyuas cov ntaub ntawv ntxaws ntxaws los pab lawv taug qab txhua qhov kev cuam tshuam no.Lwm qib ntawm kev tsis sib haum xeeb yog ntxiv los ntawm qhov tseeb tias qhov sib txawv ntawm receptors tuaj yeem tshwm sim hauv cov chaw sim sib txawv.
Bioglutide NA-931 tej zaum yuav muaj kev cuam tshuam sib txawv ntawm ntau hom ntaub so ntswg vim yog txoj kev nws cov receptors tau nthuav tawm.Thaum npaj kev tshawb fawb thiab txheeb xyuas seb cov txiaj ntsig txhais li cas, pawg tshawb fawb yuav tsum tau muab cov kev xav no ntau. Cov kws tshawb fawb tuaj yeem tau txais kev txhawb nqa los ntawm cov kws paub zoo los pab lawv nrog cov khoom no. Thaum nws los txog rau ntau -receptor peptide s, batch-rau-batch uniformity yog ib qho tseem ceeb heev vim hais tias me me molecular sib txawv yuav cuam tshuam zoo npaum li cas lawv khi rau tag nrho plaub lub receptor systems. Cov kws tshawb fawb kws tshuaj xav tau cov kws kho mob uas muaj kev tswj xyuas nruj zoo nyob rau hauv qhov chaw, xws li ntau yam kev ntsuas pov thawj. Piv txwv li, BLOOM TECH thiab lwm lub tuam txhab uas ua rau peptide paub cov qauv zoo.
Cov ntawv thov hauv Kev Tshawb Fawb Metabolic
Bioglutide NA-931 peptide muaj cov qauv tsim tshwj xeeb uas ua rau nws muaj txiaj ntsig zoo rau ntau hom kev kawm hauv kev tshawb fawb metabolic. Cov kws tshawb nrhiav uas tab tom kawm txog kev tswj hwm cov piam thaj siv cov khoom siv los saib seb cov tshuaj insulin secretion thiab rhiab heev ua haujlwm ua ke. Cov peptide yog siv los ntawm cov kws tshawb fawb kawm txog kev sib npaug ntawm lub zog los txiav txim seb yuav tswj cov kev khaws cia thiab siv lub zog li cas. Bioglutide NA-931 yog qhov muaj txiaj ntsig zoo rau cov kws tshawb fawb ua cov kev tshawb fawb ntawm incretin biology vim tias nws cia lawv sib piv cov txiaj ntsig ntawm ib leeg thiab ob txoj haujlwm incretin.
Qhov sib ntxiv ntawm glucagon thiab IGF-1 txoj hauv kev ua rau nws muaj peev xwm kawm txog kev sib koom ua ke ntawm metabolic hauv ntau qhov chaw. Kev thov yog los ntawm cov pab pawg kawm thoob plaws ntiaj teb rau kev siv ntau yam. Biotech tuam txhab uas muag ua hauj lwm rau tiam tom ntej ntawm cov tshuaj metabolic kawm tshuaj xws li Bioglutide NA-931 kom paub ntau ntxiv txog yuav ua li cas siv ntau tshaj ib tug receptor. Cov peptide yog siv los ua cov cuab yeej tshawb fawb los saib seb kev ua kom muaj ntau txoj hauv kev ib zaug zoo dua li kev ua kom cov receptors ib zaug lossis hauv qee qhov kev txiav txim. Rau cov kev kawm txhais lus siv no, peb xav tau cov chaw peptide peb tuaj yeem ntseeg tau tias paub tias peb xav tau dab tsi rau kev txhim kho tshuaj.
Xaus
Bioglutide NA-931 peptide yog cov cuab yeej kawm qib siab uas ua haujlwm nrog plaub qhov sib txawv receptor systems-GLP-1, GIP, glucagon, thiab IGF-1- los tsim kom muaj kev sib koom tes hauv metabolic. Qhov kev ua kom muaj ntau yam receptors ua rau muaj kev sib xyaw ua ke uas pab cov kws tshawb fawb kawm paub ntau ntxiv txog kev tswj cov metabolism hauv tag nrho. Txoj kev tshwj xeeb ntawm kev ua haujlwm ntawm peptide yog txawv ntawm lwm cov tshuaj ib hom phiaj, thiab nws qhia tau hais tias peb txoj kev paub txog metabolic physiology li kev sib txuas tau loj hlob li cas. Bioglutide NA-931 peptide yog siv los ntawm cov pab pawg tshawb fawb thoob plaws ntiaj teb los kawm txog incretin biology, lub zog tshuav nyiaj li cas, thiab kev sib xyaw ntawm cov cim kev loj hlob. Vim hais tias cov compound tuaj yeem ua haujlwm ntawm ob qho tib si anabolic thiab catabolic txoj hauv kev tib lub sijhawm thiab txhawb kev loj hlob cov cim, nws muab qhov chaw ua haujlwm metabolic tiav uas tuaj yeem siv rau ntau yam kev sim. Multi-receptor molecules zoo li Bioglutide NA-931 yuav tsum tau ua qhov tseem ceeb dua li kev tshawb fawb metabolic txuas ntxiv mus. Cov kws tshawb fawb ua cov kev tshawb fawb no tseem yuav tsum tau txais lawv txhais tes ntawm Bioglutide NA-931 peptide zoo nrog cov ntaub ntawv tshuaj lom neeg tag nrho. Cov tuam txhab yuav tsum tau ua hauj lwm nrog cov neeg muab kev pab uas paub yuav ua li cas nyuaj multi-receptor peptide s yog thiab xyuas kom meej tias lawv siv cov zoo tswj thaum lub sij hawm tsim khoom thiab xa.
FAQ
Bioglutide NA-931 peptide yog qhov sib txawv ntawm lwm cov GLP-1 agonists vim tias nws ua rau muaj ntau yam receptors. Ib txwm GLP-1 agonists tsuas yog ua haujlwm ntawm GLP-1 receptor. Bioglutide NA-931, ntawm qhov tod tes, ua haujlwm ntawm plaub qhov sib txawv receptor systems tib lub sijhawm: GLP-1, GIP, glucagon, thiab IGF-1. Txoj kev no muaj ntau lub hom phiaj, thiab thaum lawv siv tag nrho ua ke, lawv tsim cov teebmeem metabolic uas ua haujlwm zoo dua, zoo li cov lus teb zoo dua incretin, sib npaug zog metabolism, thiab ua ke cov cim kev loj hlob. Nws muaj peev xwm kawm txog kev sib raug zoo metabolic nrog cov peptide no uas tsis tuaj yeem ua nrog ib leeg-receptor compounds. Qhov no ua rau nws muaj txiaj ntsig zoo rau kev kawm seb lub cev lub cev ua haujlwm li cas.
Cov pab pawg tshawb fawb yuav tsum muab qhov hnyav ntxiv rau cov neeg muag khoom uas muab cov ntaub ntawv txheeb xyuas tag nrho rau txhua pawg, xws li HPLC chromatograms, cov ntaub ntawv loj spectrometry, thiab cov ntaub ntawv purity. Tus kws kho mob yuav tsum ua haujlwm hauv GMP- ib puag ncig tau lees paub thiab muaj ntau yam kev tswj hwm zoo nyob rau hauv qhov chaw thaum tsim khoom. Nrhiav cov tuam txhab uas tuaj yeem muab cov ntaub ntawv tshwj xeeb rau koj txog Bioglutide NA-931 peptide's kev nyab xeeb, solubility, thiab yuav khaws nws li cas. Cov neeg muab kev ntseeg siab tseem muab cov ntaub ntawv txhawb nqa kev cai lij choj thiab xyuas kom meej tias lawv cov kev tsim khoom ib txwm zoo ib yam kom cov khoom tuaj yeem ua los ntawm ib pawg mus rau lwm qhov. Cov koom haum yuav tsum xyuas kom meej tias lawv qhov chaw paub yuav ua li cas nyuaj multi-receptor peptide s yog thiab muaj kev tswj kom zoo nyob rau hauv qhov chaw.
Vim tias Bioglutide NA-931 peptide cuam tshuam nrog ntau cov receptors, cov kws tshawb fawb yuav tsum xav txog ntau yam kev sim. Cov peptide tuaj yeem muaj qhov sib txawv ntawm cov ntaub so ntswg sib txawv nyob ntawm seb nws cov receptors tau qhia li cas, yog li nws yog ib qho tseem ceeb uas yuav tau xaiv qhov kev ntsuam xyuas zoo. Kev sib txawv receptor rhiab heev tuaj yeem ua rau koob tshuaj- teb kev sib raug zoo nyuaj, yog li lawv yuav tsum tau ua kom zoo zoo. Cov kws tshawb fawb yuav tsum teeb tsa cov kev tswj hwm uas ua rau nws yooj yim dua los qhia seb qhov twg tshwm sim los ntawm txoj kev receptor. Txhawm rau kom peptide ruaj khov thiab lawv cov kev ua haujlwm ntau, lawv yuav tsum tau khaws cia thiab ua haujlwm kom raug. Ua hauj lwm nrog cov neeg muag khoom peptide uas muaj kev paub ntau thiab muaj peev xwm muab kev txhawb nqa tuaj yeem pab cov kws tshawb fawb los ntawm cov teeb meem no thiab tuaj nrog cov kev sim muaj zog.
Koom tes nrog BLOOM TECH rau Premium Bioglutide NA-931 peptide Supply
BLOOM TECH stands as your trusted Bioglutide NA-931 peptide supplier, offer research-qib compounds manufactured in nruj GMP condition at our US, EU, JP, and CFDA-certified production facilities. Peb 12-xyoo kev txawj ntse hauv cov organic synthesis thiab tshuaj intermediates ua kom koj tau txais peptide s nrog cov ntaub ntawv pov thawj purity (Ntau dua lossis sib npaug li 98%), cov ntaub ntawv tshuaj ntsuam xyuas dav dav suav nrog HPLC thiab MS cov ntaub ntawv, thiab ua tiav batch zoo sib xws rau cov txiaj ntsig kev tshawb fawb. Peb nkag siab tias ntau-kev tshawb fawb peptide xav tau tshwj xeeb kev tswj hwm zoo-yog vim li cas peb siv peb txheej txheej pov thawj zoo thiab muab kev txhawb nqa tag nrho rau koj cov kev txhim kho. Txawm hais tias koj yog ib lub tuam txhab tshuaj, lub koom haum biotechnology, CDMO, lossis lub chaw tshawb fawb, BLOOM TECH muab cov kev txawj ntse, cov saw hlau ruaj khov, thiab cov nqi sib tw uas ua rau koj cov kev tshawb fawb metabolic. Peb pab neeg tshaj lij muab kev pabcuam tus kheej nrog tus nqi pob tshab thiab xa sai sai kom tau raws li koj qhov project ncua sijhawm. Npaj txhij los nce koj cov kev tshawb fawb nrog cov khoom siv peptide txhim khu kev qha? Hu rau peb pab neeg hnub no ntawm Sales@bloomtechz.com los tham txog koj cov kev xav tau tshwj xeeb thiab paub txog BLOOM TECH qhov txawv ntawm qhov zoo thiab kev pabcuam.
Cov ntaub ntawv
1. Müller TD, Finan B, Bloom SR, et al. Glucagon-zoo li peptide 1 (GLP-1). Molecular Metabolism. 2019; 30:72-130.
2. Holst JJ, Rosenkilde MM. GIP raws li Kev Kho Mob Lub Hom Phiaj hauv Mob Ntshav Qab Zib thiab Kev rog: Kev Pom Zoo Los ntawm Incretin Co-agonists. Phau ntawv Journal of Clinical Endocrinology & Metabolism. 2020;105(8):e2710-e2716.
3. Svendsen B, Capozzi ME, Nui J, et al. Pharmacological antagonism ntawm lub incretin system tiv thaiv kev noj haus -induced rog. Molecular Metabolism. 2020; 32:44-55.
4. Tamrakar AK, Maurya CK, Rai AK. PTP1B inhibitors rau kev kho mob ntshav qab zib hom 2: kev tshuaj xyuas patent (2011-2014). Cov kws tshaj lij kev xav txog Kev Kho Mob Patents. 2014; 24(10): 1101-1115.
5. Campbell JE, Drucker DJ. Pharmacology, physiology, thiab mechanisms ntawm incretin hormone ua. Cell Metabolism. 2013;17(6):819-837.
6. Nauck MA, Meier JJ. Incretin hormones: Lawv lub luag haujlwm hauv kev noj qab haus huv thiab kab mob. Mob ntshav qab zib, rog rog thiab Metabolism. 2018; 20(Suppl 1:5-21.